Suppr超能文献

E2F 家族成员与 PIDDosome 结合,限制肝发育和再生过程中肝细胞的倍性。

E2F-Family Members Engage the PIDDosome to Limit Hepatocyte Ploidy in Liver Development and Regeneration.

机构信息

Division of Developmental Immunology, Biocenter, Medical University of Innsbruck, 6020 Innsbruck, Austria.

Department of Pathobiology, Faculty of Veterinary Medicine, Utrecht University, 3584 CL Utrecht, the Netherlands.

出版信息

Dev Cell. 2020 Feb 10;52(3):335-349.e7. doi: 10.1016/j.devcel.2019.12.016. Epub 2020 Jan 23.

Abstract

E2F transcription factors control the cytokinesis machinery and thereby ploidy in hepatocytes. If or how these proteins limit proliferation of polyploid cells with extra centrosomes remains unknown. Here, we show that the PIDDosome, a signaling platform essential for caspase-2-activation, limits hepatocyte ploidy and is instructed by the E2F network to control p53 in the developing as well as regenerating liver. Casp2 and Pidd1 act as direct transcriptional targets of E2F1 and its antagonists, E2F7 and E2F8, that together co-regulate PIDDosome expression during juvenile liver growth and regeneration. Of note, whereas hepatocyte aneuploidy correlates with the basal ploidy state, the degree of aneuploidy itself is not limited by PIDDosome-dependent p53 activation. Finally, we provide evidence that the same signaling network is engaged to control ploidy in the human liver after resection. Our study defines the PIDDosome as a primary target to manipulate hepatocyte ploidy and proliferation rates in the regenerating liver.

摘要

E2F 转录因子控制有丝分裂机器,从而控制肝细胞的倍性。这些蛋白质是否或如何限制具有额外中心体的多倍体细胞的增殖仍然未知。在这里,我们表明 PIDDosome 是一种对于 caspase-2 激活至关重要的信号平台,它限制了肝细胞的倍性,并受到 E2F 网络的指导,以控制发育中和再生中的肝脏中的 p53。Casp2 和 Pidd1 是 E2F1 及其拮抗剂 E2F7 和 E2F8 的直接转录靶标,它们共同在幼年肝生长和再生过程中调节 PIDDosome 的表达。值得注意的是,虽然肝细胞非整倍性与基础倍性状态相关,但非整倍性的程度本身不受 PIDDosome 依赖性 p53 激活的限制。最后,我们提供了证据表明,相同的信号网络在肝切除后被用于控制人类肝脏的倍性。我们的研究将 PIDDosome 定义为在再生肝脏中操纵肝细胞倍性和增殖率的主要靶标。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验